Preclinical studies are essential for advancing oncology drug development programs. They provide valuable insights into a drug candidate's safety and efficacy before it moves into clinical trials. A well-designed preclinical study can increase the likelihood of...
Introduction A patient-derived colon cancer Xenograft (PDX) model has been established for the first time by Noble Life Sciences by implanting cryopreserved PDX fragments into a transplant compliant mouse host. PDX models have advantages over cancer cell line...
Introduction With the increasing incidence of patients worldwide diagnosed with cancer, the development of effective, safe, and economically viable anticancer therapeutics remains a high priority. Early anticancer drug discovery and development is very challenging...
The Cancer Genome Atlas (TCGA)—a comprehensive and coordinated effort to accelerate understanding of the molecular basis of cancer through the application of genome analysis technologies, supported by the National Cancer Institute and National Human Genome Research...
The 2018 Nobel Prize in Physiology or Medicine was awarded to James P. Allison of the United States and Tasuku Honjo of Japan for their work on unleashing the body’s immune system to attack cancer, a breakthrough that has herald in an entirely new class of treatment...
Noble Life Sciences Now Offers Live Animal Imaging for Preclinical Stu PerkinElmer IVIS Lumina LT III Gain simultaneous insights into the efficacy, kinetics, target, and mechanism of action of your drug candidate non-invasively. The IVIS is particularly suited for...
WHY NOBLE LIFE SCIENCES? Dedicated Study Director for each project Highly Skilled Technical Team Qualified animal Care Team Interactive Study Design and Execution Noble’s highly experienced scientist have been implementing effective and efficient approaches to help...